Streetbeat News

Stock Prices

ATHE

Trading for ATHE was halted at 5:41:10 p.m. ET due to pending news. The halt is a temporary measure awaiting a significant announcement.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:41 pm

SNES

SenesTech reported Q4 2023 GAAP EPS of $(9.54) and sales of $295K, missing the consensus estimate of $380K by 22.37%. This represents a 0.67% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:41 pm

PSN

Parsons Corporation (NYSE:PSN) plans to offer $700 million in convertible senior notes due 2029, with an option for initial purchasers to buy an additional $100 million. The notes, accruing interest semiannually, are convertible under certain conditions and may be settled in cash or Parsons' stock. Proceeds will fund capped call transactions, repurchase existing convertible notes due 2025, and support general corporate purposes including potential acquisitions. Market activities related to this offering and capped call transactions may impact Parsons' stock price and the notes' initial conversion price.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:39 pm

MSFT

Phil Spencer, Xbox head, announced Microsoft Corp.'s plan to release all games from Activision Blizzard, ZeniMax, and Xbox Game Studios on Game Pass on their launch day, including major titles like Call of Duty. This marks a significant strategy shift, potentially impacting traditional sales models and subscriber numbers. Concerns remain among publishers about the effects of subscription services on game sales, with skepticism from figures like Take-Two CEO Strauss Zelnick. The next Call of Duty installment is expected to launch in late 2023.

Portfolio Pulse from Franca Quarneti

February 21, 2024 | 10:38 pm

STRS

Stratus Properties Inc. (STRS) received an unsolicited acquisition proposal from NXSTEP Opportunity Partners at $27.18 per share, which was later increased to $27.30 per share. Stratus' Board unanimously rejected the offer, stating it undervalues the company. Oasis Management Company Ltd., a Stratus stockholder, supports NXSTEP's proposal. Stratus plans to consider its options and respond to NXSTEP accordingly.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:35 pm

AI

BBAI

NVDA

PLTR

SOUN

Palantir Technologies Inc (PLTR) shares rose in after-hours trading following Nvidia Corp's (NVDA) better-than-expected earnings, highlighting the surging demand for AI. Nvidia reported Q4 revenue of $22.1 billion and earnings of $5.16 per share, surpassing estimates. The company's data center revenue increased by 409%, and it provided a positive revenue guidance for fiscal year 2025. Both Nvidia and Palantir have benefited from the growing AI demand, with Palantir reporting strong demand for its AI platform in early February. Other AI-related companies like C3.Ai Inc (AI), SoundHound AI Inc (SOUN), and BigBear.Ai Inc (BBAI) also saw their shares move higher.

Portfolio Pulse from Adam Eckert

February 21, 2024 | 10:33 pm

NOMD

Nomad Foods Limited (NYSE: NOMD) has provided its adjusted EPS guidance for 2024, projecting a growth of 9-12% with an EPS range of €1.75-€1.80. The company will also report its Q4 and full year results on February 29, 2024, and present at the CAGNY Conference on February 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:32 pm

RYI

Ryerson Holding (NYSE:RYI) reported Q4 2023 adjusted EPS of $0.73, surpassing the $0.26 estimate, but its sales of $1.10B fell short of the $1.12B estimate, marking a 14.60% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:32 pm

DOC

PEAK

Healthpeak Properties and Physicians Realty Trust have received approval from their respective stockholders and shareholders for a merger. Under the agreement, Physicians Realty Trust shareholders will receive 0.674 of a newly issued Healthpeak share for each share they owned prior to the merger.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:31 pm

NTR

Nutrien (NYSE:NTR) reported Q4 adjusted earnings per share of $0.37, missing the consensus estimate of $0.65, representing an 81.68% decrease from the same period last year. However, their quarterly sales of $5.66 billion exceeded the consensus estimate of $5.35 billion by 5.96%, despite being a 24.81% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 10:29 pm